Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Buntaran, Latre ^a   Hatta, Mochammad ^b   Sultan, Andi R ^b   Dwiyanti, Ressy ^c   Sabir, Muhammad ^c  

^a RSAB   (Indonesia)

^b HASANUDDIN UNIVERSITY   (Indonesia)

^c TADULAKO UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ACETAMIDE DERIVATIVE; AMIKACIN; CLINDAMYCIN; LINEZOLID; MINOCYCLINE; OXAZOLIDINONE DERIVATIVE; PRIMER DNA; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; DRUG DERIVATIVE;

ANALOGS AND DERIVATIVES; BACTERIAL GENE; COMMUNITY ACQUIRED INFECTION; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECTS; GENETICS; HUMAN; INDONESIA; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PLASMID; POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; TIME; ARTICLE; COMMUNICABLE DISEASE; DRUG EFFECT;

ACETAMIDES; AMIKACIN; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; INDONESIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINOCYCLINE; OXAZOLIDINONES; PLASMIDS; POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TEICOPLANIN; TIME FACTORS; VANCOMYCIN;

EID: 84875172299     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-110     Document Type: Article

References (48)

1. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S, Ehricht R, Coleman DC, Antimicrob Agents Chemother 2011 55 8 3765 3773 10.1128/AAC.00187-11 21636525
2. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ, J Antimicrob Chemother 2007 60 5 1018 1029 10.1093/jac/dkm310 17855724 (Pubitemid 47617749)
3. Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China. Aires de Sousa M, Crisostomo MI, Sanches IS, Wu JS, Fuzhong J, Tomasz A, de Lencastre H, J Clin Microbiol 2003 41 1 159 163 10.1128/JCM.41.1.159-163.2003 12517842 (Pubitemid 36098570)
4. Meticillin-resistant Staphylococcus aureus. Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, Kocagoz S, Oztop AY, Vandenbroucke-Grauls CM, Harbarth S, Pittet D, Lancet Infect Dis 2005 5 10 653 663 10.1016/S1473-3099(05)70243-7 16183520 (Pubitemid 41383911)
5. Korean nationwide surveillance of antimicrobial resistance of bacteria in 1998. Lee K, Chang CL, Lee NY, Kim HS, Hong KS, Cho HC, Yonsei Med J 2000 41 4 497 506 10992812
6. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Voss A, Doebbeling BN, Int J Antimicrob Agents 1995 5 2 101 106 10.1016/0924-8579(94)00036-T 18611655
7. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Klein E, Smith DL, Laxminarayan R, Emerg Infect Dis 2007 13 12 1840 1846 10.3201/eid1312.070629 18258033 (Pubitemid 350248484)
8. Community-acquired methicillin-resistant Staphylococcus aureus in children in northern Taiwan. Fang YH, Hsueh PR, Hu JJ, Lee PI, Chen JM, Lee CY, Huang LM, J Microbiol Immunol Infect 2004 37 1 29 34 15060684
9. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Sattler CA, Mason EO Jr, Kaplan SL, Pediatr Infect Dis J 2002 21 10 910 917 10.1097/00006454-200210000-00005 12394811 (Pubitemid 35176149)
10. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS, JAMA 1998 279 8 593 598 10.1001/jama.279.8.593 9486753 (Pubitemid 28110205)
11. Alternative therapies in Staphylococcus aureus diseases. Kurlenda J, Grinholc M, Acta Biochim Pol 2012 59 2 171 184 22577619
12. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, JAMA 2003 290 22 2976 2984 10.1001/jama.290.22.2976 14665659 (Pubitemid 37505530)
13. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Besser JM, O'Boyle C, Danila RN, Cheek JE, Clin Infect Dis 2001 33 7 990 996 10.1086/322693 11528570 (Pubitemid 32907100)
14. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia. Monaco M, Antonucci R, Palange P, Venditti M, Pantosti A, Emerg Infect Dis 2005 11 10 1647 1648 10.3201/eid1110.050776 16355511 (Pubitemid 41384367)
15. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. Millar BC, Prendergast BD, Moore JE, J Antimicrob Chemother 2008 61 1 1 7 10.1093/jac/dkm441 17962214
16. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM, Clin Infect Dis 2006 42 5 647 656 10.1086/499815 16447110 (Pubitemid 43271378)
17. Severe methicillin-resistant staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, december 2006-january 2007. Centers for Disease C, Prevention, MMWR Morb Mortal Wkly Rep 2007 56 14 325 329 17431376
18. Mobile genetic elements of Staphylococcus aureus. Malachowa N, DeLeo FR, Cell Mol Life Sci 2010 67 18 3057 3071 10.1007/s00018-010-0389-4 20668911
19. SCCmec in staphylococci: genes on the move. Hanssen AM, Ericson Sollid JU, FEMS Immunol Med Microbiol 2006 46 1 8 20 10.1111/j.1574-695X.2005.00009.x 16420592
20. Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. International Working Group on the Classification of Staphylococcal Cassette Chromosome E, Antimicrob Agents Chemother 2009 53 12 4961 4967 19721075
21. Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance element. Otto M, Virulence 2010 1 1 49 51 10.4161/viru.1.1.10453 21178414
22. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K, Antimicrob Agents Chemother 2001 45 5 1323 1336 10.1128/AAC.45.5.1323-1336.2001 11302791 (Pubitemid 32374098)
23. Genetics of antimicrobial resistance in Staphylococcus aureus. Jensen SO, Lyon BR, Future Microbiol 2009 4 5 565 582 10.2217/fmb.09.30 19492967
24. Antimicrobial resistance: the example of Staphylococcus aureus. Lowy FD, J Clin Invest 2003 111 9 1265 1273 12727914 (Pubitemid 36554694)
25. Staphylococcal cassette chromosome mec (Sccmec) classification and typing methods: an overview. Turlej A, Hryniewicz W, Empel J, Pol J Microbiol 2011 60 2 95 103 21905625
26. Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Kuo SC, Chiang MC, Lee WS, Chen LY, Wu HS, Yu KW, Fung CP, Wang FD, Int J Antimicrob Agents 2012 39 1 22 26 10.1016/j.ijantimicag.2011.08.014 21982834
27. Mechanisms of antibiotic resistance in Staphylococcus aureus. Pantosti A, Sanchini A, Monaco M, Future Microbiol 2007 2 3 323 334 10.2217/17460913.2.3. 323 17661706 (Pubitemid 47180928)
28. Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European antimicrobial resistance surveillance system (1999-2003). Rossney AS, Lawrence MJ, Morgan PM, Fitzgibbon MM, Shore A, Coleman DC, Keane CT, O'Connell B, Eur J Clin Microbiol Infect Dis 2006 25 2 79 89 10.1007/s10096-006-0091-5 16501928 (Pubitemid 43333668)
29. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Popovich KJ, Weinstein RA, Hota B, Clin Infect Dis 2008 46 6 787 794 10.1086/528716 18266611 (Pubitemid 351417176)
30. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Davis SL, Rybak MJ, Amjad M, Kaatz GW, McKinnon PS, Infect Control Hosp Epidemiol 2006 27 10 1025 1031 10.1086/507918 17006808 (Pubitemid 44670977)
31. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. Sieradzki K, Roberts RB, Haber SW, Tomasz A, N Engl J Med 1999 340 7 517 523 10.1056/NEJM199902183400704 10021472 (Pubitemid 29093287)
32. Emergence of vancomycin resistance in staphylococcus aureus. Glycopeptide-intermediate staphylococcus aureus working group. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, N Engl J Med 1999 340 7 493 501 10.1056/NEJM199902183400701 10021469 (Pubitemid 29093284)
33. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Moore MR, Perdreau-Remington F, Chambers HF, Antimicrob Agents Chemother 2003 47 4 1262 1266 10.1128/AAC.47.4.1262-1266. 2003 12654656 (Pubitemid 36368583)
34. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML, Clin Microbiol Rev 2010 23 1 99 139 10.1128/CMR.00042-09 20065327
35. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K, Drug Resist Updat 2003 6 1 41 52 10.1016/S1368-7646(03)00003-7 12654286 (Pubitemid 36396113)
36. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Oliveira DC, Tomasz A, de Lencastre H, Microb Drug Resist 2001 7 4 349 361 10.1089/10766290152773365 11822775 (Pubitemid 34106309)
37. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Oliveira DC, de Lencastre H, Antimicrob Agents Chemother 2002 46 7 2155 2161 10.1128/AAC.46.7.2155-2161.2002 12069968 (Pubitemid 34665910)
38. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K, Mol Microbiol 2003 49 3 807 821 12864861 (Pubitemid 36918698)
39. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, J Infect Dis 2003 187 4 613 624 10.1086/374001 12599078 (Pubitemid 36250025)
40. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Katayama Y, Ito T, Hiramatsu K, Antimicrob Agents Chemother 2000 44 6 1549 1555 10.1128/AAC.44.6.1549-1555.2000 10817707 (Pubitemid 30340793)
41. Bacterial resistance mechanisms for tetracyclines. Yamaguchi A, Nihon Rinsho 1997 55 5 1245 1251 9155182
42. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. Matsuhashi M, Song MD, Ishino F, Wachi M, Doi M, Inoue M, Ubukata K, Yamashita N, Konno M, J Bacteriol 1986 167 3 975 980 3638304 (Pubitemid 16045033)
43. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ, J Hosp Infect 1998 38 4 273 281 10.1016/S0195-6701(98)90076-7 9602976 (Pubitemid 28187948)
44. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A, J Clin Microbiol 2000 38 11 3926 3931 11060046 (Pubitemid 32233183)
45. Ethnicity and methicillin-resistant S. aureus in South Auckland. Rings T, Findlay R, Lang S, N Z Med J 1998 111 1064 151 9612479 (Pubitemid 28212890)
46. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Stacey AR, Endersby KE, Chan PC, Marples RR, Br J Sports Med 1998 32 2 153 154 10.1136/bjsm.32.2.153 9631224 (Pubitemid 28271452)
47. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Embil J, Ramotar K, Romance L, Alfa M, Conly J, Cronk S, Taylor G, Sutherland B, Louie T, Henderson E, Infect Control Hosp Epidemiol 1994 15 10 646 651 10.1086/646827 7844335
48. A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA). Hanaki H, Inaba Y, Sasaki K, Hiramatsu K, Jpn J Antibiot 1998 51 8 521 530 9836124 (Pubitemid 28417126)